Skip to Content
Merck
All Photos(1)

Key Documents

M6908

Sigma-Aldrich

Myeloperoxidase from human leukocytes

lyophilized powder, ≥50 units/mg protein

Synonym(s):

MPO, Peroxidase, myelo

Sign Into View Organizational & Contract Pricing


About This Item

CAS Number:
Enzyme Commission number:
MDL number:
UNSPSC Code:
12352200
NACRES:
NA.32

biological source

human leucocytes

Quality Level

form

lyophilized powder

specific activity

≥50 units/mg protein

solubility

H2O: soluble
aqueous buffers such as 50 mM sodium acetate: soluble (Freezing of the enzyme in solution may result in a substantial loss of activity.)

UniProt accession no.

shipped in

dry ice

storage temp.

−20°C

InChI

1S/H2O3/c1-3-2/h1-2H

InChI key

JSPLKZUTYZBBKA-UHFFFAOYSA-N

Gene Information

human ... MPO(4353)

Looking for similar products? Visit Product Comparison Guide

General description

Myeloperoxidase (MPO) is encoded by the gene mapped to human chromosome 17q22-24. The encoded protein is a leukocyte-derived enzyme and is an integral constituent of the innate immune response. MPO belongs to the heme peroxidase superfamily. MPO is a heme protein containing iron and is highly expressed in leukocytes, neutrophils, monocytes and some subtypes of tissue macrophages.

Application

Myeloperoxidase (MPO) from human leukocytes has been used in MPO assay.
Myeloperoxidase from human leukocytes has been used:
  • as a standard to quantify the neutrophil (polymorphonuclear cell [PMN]) infiltration in lung tissue
  • as a neutrophil extracelullar trap (NET) component to stimulate 106 dendritic cells or 106 macrophages
  • as a standard in myeloperoxidase (MPO) assay to measure pancreatic MPO

Biochem/physiol Actions

Myeloperoxidase (MPO) has a crucial role to play in destruction of various microorganisms and foreign cells, such as bacteria, fungi, viruses, red cells and malignant and nonmalignant nucleated cells. MPO catalyzes the production of number of reactive oxidant species (ROS) that influence tissue damage during inflammation. MPO and its downstream inflammatory pathways function as a potent therapeutic target for prophylaxis of atherosclerotic cardiovascular disease. MPO catalyze the synthesis of polychlorinated dibenzo(p)dioxins and furans (PCDD/F) from precursor such as chlorophenols in presence of hydrogen peroxide (H2O2).

Other Notes

Lysosomal heme-containing protein.

Unit Definition

One unit of myeloperoxidase will catalyze the consumption of one micromole of hydrogen peroxide and the production of 1/4 micromole of tetraguaiacol per minute at pH 7.0 and 25 °C

Physical form

Lyophilized from 50 mM sodium acetate buffer, pH 6.0, 0.1 M sodium chloride

Analysis Note

Source material tested and found negative for antibody to HIV and for HBSAG.

Storage Class Code

11 - Combustible Solids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

The localization of the human myeloperoxidase gene is in close proximity to the translocation breakpoint in acute promyelocytic leukemia.
Chang KS
Leukemia, 1(15), 458-462 (1987)
Piezo1 is a mechanically activated ion channel and mediates pressure induced pancreatitis
Romac JMJ, et al.
Nature Communications, 9(1715), 1-10 (2018)
Sharbel Weidner Maluf et al.
Genetics and molecular biology, 43(2), e20180390-e20180390 (2020-06-20)
The objective of this study was to evaluate the level of genomic instability in patients with celiac disease and to establish a relationship between inflammation, oxidative stress, and DNA damage in these patients. Myeloperoxidase (MPO) activity, adenosine deaminase, nitric oxide
Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice.
Bergeron Y
Infection and Immunity, 66(3), 912-922 (1998)
Clinical manifestation of myeloperoxidase deficiency.
Lanza F
Journal of Molecular Medicine, 76(10), 676-681 (1998)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service